Narcotic-induced hypogonadism during therapy for heroin addiction

Journal of Addictive Diseases

Volumn 21, Issue 4, 2002, Pages 47-53

  Daniell, Harry W ^a  

^a NONE   (United States)

Author keywords

Androgens; Drug therapy; Hypogonadism; Narcotics; Opioid related disorders

Indexed keywords

ACETYLMETHADOL; ANDROSTANOLONE; DIAMORPHINE; ESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; METHADONE; NALTREXONE; NARCOTIC AGENT; OPIATE ANTAGONIST; SEX HORMONE; TESTOSTERONE;

AMENORRHEA; ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; FATIGUE; FEMALE; HEROIN DEPENDENCE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPOGONADISM; LIBIDO; MALE; METHADONE TREATMENT; QUALITY OF LIFE; SEXUAL DYSFUNCTION;

ANDROGENS; HEROIN DEPENDENCE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; NARCOTICS;

EID: 0036399514     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v21n04_05     Document Type: Article

References (21)

1. Mendelson JH, Mello NK. Plasma testosterone levels during chronic heroin use and protracted abstinence. A study of Hong Kong addicts. Clin Pharmacol Ther. 1975;17:529-533.
2. Mendelson JH, Mendelson JE, Patch VD. Plasma testosterone levels in heroin addiction and during methadone maintenance. J Pharmacol Exp Ther. 1975;192:211-217.
3. Cicero TJ, Bell RD, Wiest WG, et al. Function of the male sex organs in heroin and methadone users. N Engl J Med. 1975;292:882-887.
4. O'Connor PG, Fiellin DA. Pharmacologic treatment of heroin-dependent patients. Ann Intern Med. 2000;133:40-54.
5. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in main-stream medicine. Ann NY Acad Sci. 2000;909(2):186-216.
6. Mendelson JH, Inturrisi CE, Renault P, et al. Effects of acetylmethadol on plasma testosterone. Clin Pharmacol Ther. 1976;19(3):371-374.
7. Mendelson JH, Meyer RE, Ellingboe J, et al. Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther. 1975;195:296-302.
8. Woody G, McLellan T, O'Brien C, et al. Hormone secretion in methadone-dependent and abstinent patients. NIDA Res Monogr. 1988;81:216-223.
9. Azizi F, Vagenakis AG, Longcope C, et al. Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids. 1973;22:467-472.
10. Cushman P, Kreek MJ. Methadone-maintenance patients, effect of methadone on plasma testosterone, FSH, LH, and prolactin. NY State J Med. 1974;74:1970-1973.
11. Mirin SM, Mendelson JH, Ellingboe J, et al. Acute effects of heroin and naltrexone on testosterone and gonadotropin secretion. A pilot study. Psychoneurdocrinology. 1976;1:359-369.
12. Bolelli G, Lafisca S, Flamigni C, et al. Heroin addiction: Relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin. Toxicology. 1979;15:19-29.
13. Lafisca S, Bolelli G, Franceschetti F, et al. Hormone levels in methadone-treated drug addicts. Drug Alcohol Dep. 1981;8:229-234.
14. Ragni G, DeLauretis L, Bestetti O, et al. Gonadal function in male heroin and methadone addicts. Int Jour Andrology. 1988;11:93-100.
15. Daniell HW. The association of endogenous hormone levels and exogenously administered opiates in males. AJPM. 2001;11:8-10.
16. Coiro V, Passeri M, Volpi M, et al. Different effects of aging on the opioid mechanisms controlling gonadotrophin and cortisol secretion in man. Horm Res. 1989;32:119-123.
17. Adams ML, Sewing B, Forman JB, et al. Opioid-induced suppression of rat testicular function. J Pharmacol Exp Ther. 1993;266:323-328.
18. Facchinetti F, Comitini G, Petraglia F, et al. Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur J Obstet Gynecol Reprod Biol. 1986;23:67-73.
19. Hemmings R, Fox G, Tolis G. Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women. Fertil and Steril. 1982;37:389-391.
20. Johnson RE, Chutuape MN, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. NEJM. 2000;343: 1290-1297.
21. Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence. JAMA. 2000;283:1303-1310.